A Prognostic Model for Time-To-Failure in P16-Negative Patients Provides Useful Risk Stratification in P16-Positive Patients

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2015.12.321
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Survival Outcomes of Marijuana Users in P16 Positive Oropharynx Cancer Patients

Journal of Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2019English

Significance of Negative Posttreatment 18-FDG PET/CT Imaging in Patients With P16/HPV-positive Oropharyngeal Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

HPV-DNA Positive/P16 IHC Negative Oral Squamous Cell Carcinoma: A Case Report

Proceedings
2019English

Immunohistochemical Biomarkers and Volumetric Parameters for Predicting Radiotherapy-Based Outcomes in Patients With P16-Negative Pharyngeal Cancer

Oncotarget
Oncology
2017English

Imatinib-Associated Matrix Metalloproteinase Suppression in P16-Positive Squamous Cell Carcinoma Compared to HPV-negative HNSCC Cells in Vitro

Oncology Reports
MedicineCancer ResearchOncology
2014English

The Prognostic Value of P16 Hypermethylation in Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Correction To: HPV DNA in Saliva From Patients With SCC of the Head and Neck Is Specific for P16-Positive Oropharyngeal Tumours

Journal of Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2018English

Metabolic Profile Provides Prognostic Value Better Than Galectin-3 in Patients With Heart Failure

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Coronary Risk Stratification of Patients With Newly Diagnosed Heart Failure

Open Heart
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy